Javascript must be enabled to continue!
Data from NKX3.1 Suppresses <i>TMPRSS2–ERG</i> Gene Rearrangement and Mediates Repair of Androgen Receptor–Induced DNA Damage
View through CrossRef
<div>Abstract<p><i>TMPRSS2</i> gene rearrangements occur at DNA breaks formed during androgen receptor–mediated transcription and activate expression of <i>ETS</i> transcription factors at the early stages of more than half of prostate cancers. NKX3.1, a prostate tumor suppressor that accelerates the DNA repair response, binds to androgen receptor at the <i>ERG</i> gene breakpoint and inhibits both the juxtaposition of the <i>TMPRSS2</i> and <i>ERG</i> gene loci and also their recombination. NKX3.1 acts by accelerating DNA repair after androgen-induced transcriptional activation. NKX3.1 influences the recruitment of proteins that promote homology-directed DNA repair. Loss of NKX3.1 favors recruitment to the <i>ERG</i> gene breakpoint of proteins that promote error-prone nonhomologous end-joining. Analysis of prostate cancer tissues showed that the presence of a <i>TMPRSS2–ERG</i> rearrangement was highly correlated with lower levels of NKX3.1 expression consistent with the role of NKX3.1 as a suppressor of the pathogenic gene rearrangement. <i>Cancer Res; 75(13); 2686–98. ©2015 AACR</i>.</p></div>
Title: Data from NKX3.1 Suppresses <i>TMPRSS2–ERG</i> Gene Rearrangement and Mediates Repair of Androgen Receptor–Induced DNA Damage
Description:
<div>Abstract<p><i>TMPRSS2</i> gene rearrangements occur at DNA breaks formed during androgen receptor–mediated transcription and activate expression of <i>ETS</i> transcription factors at the early stages of more than half of prostate cancers.
NKX3.
1, a prostate tumor suppressor that accelerates the DNA repair response, binds to androgen receptor at the <i>ERG</i> gene breakpoint and inhibits both the juxtaposition of the <i>TMPRSS2</i> and <i>ERG</i> gene loci and also their recombination.
NKX3.
1 acts by accelerating DNA repair after androgen-induced transcriptional activation.
NKX3.
1 influences the recruitment of proteins that promote homology-directed DNA repair.
Loss of NKX3.
1 favors recruitment to the <i>ERG</i> gene breakpoint of proteins that promote error-prone nonhomologous end-joining.
Analysis of prostate cancer tissues showed that the presence of a <i>TMPRSS2–ERG</i> rearrangement was highly correlated with lower levels of NKX3.
1 expression consistent with the role of NKX3.
1 as a suppressor of the pathogenic gene rearrangement.
<i>Cancer Res; 75(13); 2686–98.
©2015 AACR</i>.
</p></div>.
Related Results
Abstract 1667: Prostatitis related mitogenic stimuli cause loss of NKX3.1: Increased risk for prostate cancer
Abstract 1667: Prostatitis related mitogenic stimuli cause loss of NKX3.1: Increased risk for prostate cancer
Abstract
NKX3.1 is a haploinsufficient prostate cancer suppressor which has been shown to be reduced in most of the primary human prostate cancers. Reduced NKX3.1 ex...
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Abstract
Background: Age-associated epigenetic alteration is the underlying cause of DNA damage in aging cells. Two types of youth-associated DNA-protection epigenetic mark...
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Introduction: The United States currently faces two opioid crises, an evolved crisis currently manifesting as widespread abuse of illicit opioids, and a crisis in pain management l...
Data from Genome-wide DNA Methylation Events in <i>TMPRSS2–ERG</i> Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with <i>miR-26a</i> Hypermethylation
Data from Genome-wide DNA Methylation Events in <i>TMPRSS2–ERG</i> Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with <i>miR-26a</i> Hypermethylation
<div>Abstract<p>Prostate cancer is the second most common cancer among men worldwide. Alterations in the DNA methylation pattern can be one of the leading causes for pr...
Abstract 4679: A novel assay to predict susceptibility to tobacco-induced disease.
Abstract 4679: A novel assay to predict susceptibility to tobacco-induced disease.
Abstract
Background: Tobacco misuse is the leading preventable cause of morbidity and mortality in the world. Tobacco-induced DNA damage is one of the main mechanism...
Abstract 354: Monitor androgen blockade therapy with functional androgen receptor reporting system
Abstract 354: Monitor androgen blockade therapy with functional androgen receptor reporting system
Abstract
Hormonal manipulation remains the first line treatment for advanced prostate cancer. It includes surgical and medical means of androgen deprivation and andr...
Abstract B006: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
Abstract B006: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
Abstract
Background: Age-adjusted incidence and mortality rates for prostate cancer (PCa) among African American (AA) men are 1.6- and 2.4-fold greater, respectively...
Abstract PR04: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
Abstract PR04: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
Abstract
Background: Age-adjusted incidence and mortality rates for prostate cancer (PCa) among African American (AA) men are 1.6- and 2.4-fold greater, respectively...

